CRISPR Craze to Transform Cardiac Biology

Sebastiaan Johannes van Kampen; Eva van Rooij

doi:10.1016/j.molmed.2019.06.008

CRISPR Craze to Transform Cardiac Biology

Sebastiaan Johannes van Kampen, Eva van Rooij

Hubrecht Institute

Research output: Contribution to journal/periodical › Article › Scientific › peer-review

16 Citations (Scopus)

Abstract

Clustered regularly interspaced short palindromic repeats (CRISPR) has revolutionized many research areas and has rapidly become the gold standard in genome editing by outrivaling all other available tools. Its unprecedented versatility creates the opportunity to modify any aspect of gene regulation. Even though the cardiac field is starting to appreciate the potential of CRISPR, many applications to study cardiac biology and disease so far have remained untouched. In particular, CRISPR-based strategies that act independent of the homology-directed repair pathway could help circumvent issues of modifying the genome of postmitotic cardiomyocytes, which is currently limiting its utility in the heart. Here, we review current applications and future potential for the use of CRISPR to study cardiac biology and disease.

Original language	English
Pages (from-to)	791-802
Number of pages	12
Journal	Trends in Molecular Medicine
Volume	25
Issue number	9
DOIs	https://doi.org/10.1016/j.molmed.2019.06.008
Publication status	Published - Sept 2019

Access to Document

10.1016/j.molmed.2019.06.008

Cite this

@article{8e3a7f76cdc7459c9bb4dc5a32778f8e,

title = "CRISPR Craze to Transform Cardiac Biology",

abstract = "Clustered regularly interspaced short palindromic repeats (CRISPR) has revolutionized many research areas and has rapidly become the gold standard in genome editing by outrivaling all other available tools. Its unprecedented versatility creates the opportunity to modify any aspect of gene regulation. Even though the cardiac field is starting to appreciate the potential of CRISPR, many applications to study cardiac biology and disease so far have remained untouched. In particular, CRISPR-based strategies that act independent of the homology-directed repair pathway could help circumvent issues of modifying the genome of postmitotic cardiomyocytes, which is currently limiting its utility in the heart. Here, we review current applications and future potential for the use of CRISPR to study cardiac biology and disease.",

author = "{van Kampen}, {Sebastiaan Johannes} and {van Rooij}, Eva",

year = "2019",

month = sep,

doi = "10.1016/j.molmed.2019.06.008",

language = "English",

volume = "25",

pages = "791--802",

journal = "Trends in Molecular Medicine",

issn = "1471-4914",

publisher = "Elsevier B.V.",

number = "9",

}

TY - JOUR

T1 - CRISPR Craze to Transform Cardiac Biology

AU - van Kampen, Sebastiaan Johannes

AU - van Rooij, Eva

PY - 2019/9

Y1 - 2019/9

N2 - Clustered regularly interspaced short palindromic repeats (CRISPR) has revolutionized many research areas and has rapidly become the gold standard in genome editing by outrivaling all other available tools. Its unprecedented versatility creates the opportunity to modify any aspect of gene regulation. Even though the cardiac field is starting to appreciate the potential of CRISPR, many applications to study cardiac biology and disease so far have remained untouched. In particular, CRISPR-based strategies that act independent of the homology-directed repair pathway could help circumvent issues of modifying the genome of postmitotic cardiomyocytes, which is currently limiting its utility in the heart. Here, we review current applications and future potential for the use of CRISPR to study cardiac biology and disease.

AB - Clustered regularly interspaced short palindromic repeats (CRISPR) has revolutionized many research areas and has rapidly become the gold standard in genome editing by outrivaling all other available tools. Its unprecedented versatility creates the opportunity to modify any aspect of gene regulation. Even though the cardiac field is starting to appreciate the potential of CRISPR, many applications to study cardiac biology and disease so far have remained untouched. In particular, CRISPR-based strategies that act independent of the homology-directed repair pathway could help circumvent issues of modifying the genome of postmitotic cardiomyocytes, which is currently limiting its utility in the heart. Here, we review current applications and future potential for the use of CRISPR to study cardiac biology and disease.

U2 - 10.1016/j.molmed.2019.06.008

DO - 10.1016/j.molmed.2019.06.008

M3 - Article

C2 - 31326354

SN - 1471-4914

VL - 25

SP - 791

EP - 802

JO - Trends in Molecular Medicine

JF - Trends in Molecular Medicine

IS - 9

ER -

CRISPR Craze to Transform Cardiac Biology

Abstract

Access to Document

Fingerprint

Cite this